CJC-1295 NO DAC (5 mg Vial) Dosage Protocol

Quickstart Highlights

CJC-1295 NO DAC dosage protocols leverage this synthetic 29‑amino‑acid GHRH analog (also known as Modified GRF 1–29 or Mod GRF) to stimulate natural, pulsatile growth hormone secretion from the pituitary gland^[1]^[2]. Unlike exogenous GH administration, CJC-1295 NO DAC preserves the body’s physiologic feedback loop, supporting enhanced GH and IGF‑1 levels while maintaining natural hormonal rhythms^[3]^[4]. Research suggests benefits may include improved body composition, enhanced recovery, better sleep quality, and support for lean muscle mass and metabolic function^[5]^[6]. This educational protocol presents a practical once‑daily subcutaneous approach using a dilution optimized for clear insulin‑syringe measurements.

Reconstitute: Add 3.0 mL bacteriostatic water → ~1.67 mg/mL concentration.

Typical daily range: 100–300 mcg once daily (gradual titration).

Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U‑100 insulin syringe.

Storage: Lyophilized: refrigerate at 2–8 °C (35.6–46.4 °F); after reconstitution, refrigerate and use within 1–2 weeks; for longer storage, freeze at ≤−20 °C (≤−4 °F).

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Approach (3 mL = ~1.67 mg/mL)

Week	Daily Dose (mcg)	Units (per injection) (mL)
Weeks 1–2	100 mcg	6 units (0.06 mL)
Weeks 3–4	150 mcg	9 units (0.09 mL)
Weeks 5–6	200 mcg	12 units (0.12 mL)
Weeks 7–12	250–300 mcg	15–18 units (0.15–0.18 mL)

Frequency: Inject once daily subcutaneously, typically at bedtime to align with natural nocturnal GH pulsatility^[2]^[3]. For ≤10‑unit (≤0.10 mL) administrations (Weeks 1–4), consider 30‑ or 50‑unit insulin syringes for improved readability.

Reconstitution Steps

Draw 3.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming.

Gently swirl/roll until dissolved (do not shake).

Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Plan based on an 8–12 week daily protocol with gradual titration.

Peptide Vials (CJC-1295 NO DAC, 5 mg each):

8 weeks ≈ 2 vials
12 weeks ≈ 3 vials
16 weeks ≈ 4 vials

Insulin Syringes (U‑100):

Per week: 7 syringes (1/day)
8 weeks: 56 syringes
12 weeks: 84 syringes
16 weeks: 112 syringes

Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.

8 weeks (2 vials): 6 mL → 1 × 10 mL bottle
12 weeks (3 vials): 9 mL → 1 × 10 mL bottle
16 weeks (4 vials): 12 mL → 2 × 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each day.

Per week: 14 swabs (2/day)
8 weeks: 112 swabs → recommend 2 × 100‑count boxes
12 weeks: 168 swabs → recommend 2 × 100‑count boxes
16 weeks: 224 swabs → recommend 3 × 100‑count boxes

View Supplier

Protocol Overview

Concise summary of the once‑daily regimen.

Goal: Stimulate pulsatile GH release and elevate IGF‑1 levels to support body composition, recovery, and overall metabolic health^[2]^[5].

Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).

Dose Range: 100–300 mcg daily with gradual titration.

Reconstitution: 3.0 mL per 5 mg vial (~1.67 mg/mL) for accurate unit measurements.

Storage: Lyophilized refrigerated or frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Research Disclaimer